Automated insulin delivery for type 1 diabetes study
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 7 years old (if a child) or 18 years old (if an adult).
- You must have had type 1 diabetes for at least 6 months (children) or 3 years (adults).
- You must have used a continuous glucose monitor (CGM) for at least 6 months.
- Your doctor must approve you starting an automated insulin delivery (AID) system for this study.
- You cannot be using certain other medicines (like steroids or non-insulin diabetes drugs), have severe heart disease, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
This study tests whether an automated insulin delivery system can manage blood sugar without telling it when you eat. It combines your existing pump and continuous glucose monitor with special software, and may reduce the need for carb counting.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.